🟢 First Tracks Biotherapeutics is trading 5% up today amid XBI's 2.20% regular-session gain

First Tracks Biotherapeutics is trading 5.04% higher at $35.85, with biotech-sector strength providing broader context.

• The XBI is up 2.20% during the regular session.
• On October 15, the company announced a $200 million private placement, selling shares at $32.75; the announcement does not establish that the financing caused the gain.
• Positive ANB033 Phase 1b results were announced October 12, but no clear evidence ties that earlier news to this session’s move.